Guided Therapeutics (GTHP) Return on Capital Employed Growth (3y) (2015 - 2026)
Guided Therapeutics (GTHP) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 370.00 |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | -15,376.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14,555.00 |
| Dec 31, 2025 | -22,350.00 |
| Sep 30, 2025 | -7,506.00 |
| Jun 30, 2025 | -826.00 |
| Mar 31, 2025 | -1,196.00 |
| Dec 31, 2024 | -1,709.00 |
| Sep 30, 2024 | -2,496.00 |
| Jun 30, 2024 | -412.00 |
| Mar 31, 2024 | 5,688.00 |
| Dec 31, 2023 | 10,006.00 |
| Sep 30, 2023 | 13,107.00 |
| Jun 30, 2023 | 18,308.00 |
| Mar 31, 2023 | 41,609.00 |
| Dec 31, 2022 | 25,841.00 |
| Sep 30, 2022 | 10,386.00 |
| Jun 30, 2022 | 3,905.00 |
| Mar 31, 2022 | 4,516.00 |
| Dec 31, 2021 | 4,607.00 |
| Sep 30, 2021 | 5,015.00 |
| Jun 30, 2021 | 2,850.00 |